Molex to acquire Vectura Group from Philip Morris International for £298m.

Molex, a manufacturer of electronic, electrical, and fiber optic connectivity systems, agreed to acquire Vectura Group, a British pharmaceuticals company which develops inhaled medicines and makes inhaler devices, from Philip Morris International, an American multinational tobacco company, for £298m. “The acquisition of Vectura is the latest step in building an industry-leading capability in medical. It also demonstrates Molex’s commitment to acquiring opportunities to better serve market needs across our portfolio," Joe Nelligan, Molex CEO.